Purpose To systematically review the literature evaluating clinical utility of imaging metrics
derived from baseline fluorine-18 fluorodeoxyglucose positron emission …

Observer-driven pattern recognition is the standard for interpretation of medical images. To
achieve global parity in interpretation, semi-quantitative scoring systems have been …

This phase 2 trial evaluated PET-adapted nivolumab alone or in combination with
ifosfamide, carboplatin, and etoposide (NICE) as first salvage therapy and bridge to …

Purpose Identifying patients at high risk of progression and early death among those with
high-tumor-burden follicular lymphoma (FL) is unsatisfactory with current prognostic models …

Circulating tumor DNA (ctDNA) sequencing guides therapy decisions but has been studied
mostly in small cohorts without sufficient follow-up to determine its influence on overall …

We tested baseline positron emission tomography (PET)/computed tomography (CT) as a
measure of total tumor burden to better identify high-risk patients with early-stage Hodgkin …

Total metabolic tumor volume (TMTV), calculated from 18F-FDG PET/CT baseline studies, is
a prognostic factor in diffuse large B-cell lymphoma (DLBCL) whose measurement requires …

PURPOSE The prognosis of patients with early-stage unfavorable Hodgkin lymphoma
remains unsatisfactory. We assessed the efficacy and safety of brentuximab vedotin plus …

Our aim was to introduce and validate qPSMA, a semiautomatic software package for whole-
body tumor burden assessment in prostate cancer patients using 68Ga-prostate-specific …

Purpose Metabolic tumour volume (MTV) is a promising prognostic indicator in diffuse large
B cell lymphoma (DLBCL). Optimal thresholds to divide patients into 'low'versus 'high'MTV …